Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma
β Scribed by Luca Giovanella; Luca Ceriani; Marco Maffioli
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 112 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Knowing the postsurgery thyroglobulin (Tg) kinetic would enable its rationale for use in patients with differentiated thyroid cancer (DTC). Heterogeneous results were previously reported, then we aimed to evaluate the postsurgery Tg kinetic in a large group of patients with DTC.
Methods
Enrolled were 96 patients with DTC. Serum Tg was measured first at 5 minutes, then at 24, 48, 72, 96, and 120 hours after thyroidectomy. The Tg halfβlife (Tg[t~1/2~]) was estimated in a 1βcompartment model. A simplified 2βpoint formula (24 and 120 hours) was also used.
Results
The mean Tg(t~1/2~) was 28.53 to 30.22 hours in 1βcompartment model and 27.39 hours when estimated by a simplified formula. A strong interβmethods relationship was found (p < .001).
Conclusions
A reliable Tg(t~1/2~) estimation could be obtained by a simplified formula requiring only 2 postsurgery Tg measurements (24 and 120 hours, respectively). Β© 2009 Wiley Periodicals, Inc. Head Neck, 2010
π SIMILAR VOLUMES
To assess the value of serum thyroglobulin (Tg) levels in the follow-up of differentiated thyroid carcinoma after ablative therapy simultaneous Tg estimations and radioiodine (I3'I) scans were performed on patients during an 18-month follow-up period. In this study, 287 scans were performed on 200 p
## Abstract Measurement of serum thyroglobulin (Tg) is a highly specific test in the management of patients with differentiated thyroid cancer (DTC) after surgical treatment. The aim of our study was to evaluate and compare Tg levels in these patients found by radioimmunoassay (RIA) and immunoradio
This study delineates tumor characteristics which predispose serum thyroglobulin (TG) to be undetectable in patients in spite of persistent or recurrent differentiated thyroid cancer. Three hundred seventy four thyroid carcinoma patients with completed thyroid ablation were investigated by means of